Sign up to save your podcasts
Or
Share Mazyar Shadman, MD, MPH, Reports the Latest BTKi News in CLL
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Mazyar Shadman, MD, MPH, Reports the Latest BTKi News in CLL
Dr. Shadman of the Fred Hutchinson Cancer Center in Seattle rounds up the latest news in chronic lymphocytic leukemia (CLL) from the summer conferences, including updates on novel Bruton tyrosine kinase inhibitor (BTKi) therapies in CLL.
View all episodes
By Rahul Banerjee, MD
4.8
2727 ratings
Dr. Shadman of the Fred Hutchinson Cancer Center in Seattle rounds up the latest news in chronic lymphocytic leukemia (CLL) from the summer conferences, including updates on novel Bruton tyrosine kinase inhibitor (BTKi) therapies in CLL.